News & Updates

The nonsteroidal topical aryl hydrocarbon receptor (AHR)-modulating agent tapinarof 1% trumped a vehicle control cream in reducing the severity and manifestations of plaque psoriasis, according to the phase III PSOARING 1 and 2 trials.

Paediatric atopic dermatitis shows four distinct clusters of serum biomarker profiles, only one of which shows marked similarity to adult biomarker clusters, a recent study has found.

The risk of psoriasis is elevated in patients with continuous metabolic syndrome (MetS) and in those with newly developed MetS, a recent study has found. In contrast, such risk is absent in individuals with only a history of MetS.

Depression is not uncommon among children, adolescents, and adults with hidradenitis suppurativa (HS), reports a study, adding that periodic screening for depression may be necessary.

Treatment with apremilast appears safe and effective against mild to moderate plaque psoriasis, according to a recent study.

Ritlecitinib and brepocitinib, both Janus kinase (JAK) inhibitors, show promising efficacy for the treatment of alopecia areata (AA), a new trial has found.